Hormone Panel

(FHP™) is a dynamic mapping of the free-fraction levels of estradiol (E2) and progesterone (P) throughout one cycle. The panel also includes a cycle average value for free testosterone and DHEA/DHEA-S. This panel uses 11 saliva samples collected during specified time slots throughout a menstrual cycle. The expanded panel version includes five additional FSH and LH measurements.

The FHP™ is used to identify menstrual cycle deficits and imbalances in progesterone, estrogen, testosterone and DHEA/DHEA-S. This panel provides a profile of the hormone fluctuations in a woman’s cycle for test-guided Bioidentical Hormone Replacement Therapy. The FHP™ test is most applicable in cycling women with any of the following conditions:

• Weight gain.

• Functional infertility.

• Osteoporosis.

• Endometriosis and ovarian cysts.

• Fibroids and fibrocystic breasts.

• Increased risk of breast cancer.

• Recurrent cycle-related symptoms and irregularities, such as PMS, migraines, breast tenderness, emotional and cognitive issues, insomnia and spotting.